Upcoming Events

Centered around the theme of "Medical Ethics, Innovation, and Global Competition in Clinical Research," the congress comprehensively addressed critical topics such as system-driven approaches in clinical trials, current regulations, study start-up processes, operational excellence at investigative sites, EMR integration, and the ethical responsibilities of AI-supported medical applications, presented by expert academics. This highly attended event, with productive discussions, successfully brought together industry and government representatives.

At the Expomed Eurasia 2026 Exhibition, the latest innovations in medical technologies, laboratory solutions, and digital healthcare were closely evaluated. Alongside exploring new collaboration opportunities with global sector leaders and healthcare professionals, significant emphasis was placed on conducting key discussions regarding the evolving MDR (Medical Device Regulation) requirements, certification pathways, and the essential clinical trials needed for market access.

The 3rd Rare Diseases Symposium, organized by the Ankara University Rare Diseases Application and Research Center on February 27, 2026, comprehensively addressed integrated national solutions for rare diseases in Turkey, interdisciplinary approaches to Fabry disease, hypophosphatasia diagnosis, targeted therapies in neuronal ceroid lipofuscinosis, and hereditary angioedema cases. The scientific program also delivered critical insights into the patient journey in cystic fibrosis, the clinical utility of long-read sequencing technologies in diagnostics, early screening algorithms, and current research regarding lysosomal storage disorders.

The 8th "Ankara Genetics Days" at Ankara University, hosted alongside Dean Prof. Dr. Zehra Aycan and Department Head Prof. Dr. Hatice Ilgın Ruhi. Held as part of the "Rare Diseases Event" series, this year's seminar focused on "Rare Endocrine Diseases from a Medical Genetics Perspective." It was an excellent session dedicated to analyzing rare clinical cases and raising critical awareness for these complex disorders.

Atlant Clinical had the opportunity to attend the TÜKSA Introduction Meeting held on February 11th in Ankara. The event served as an excellent networking platform, bringing together pharmaceutical and healthcare industry leaders to enhance industry visibility and explore potential avenues for strategic collaboration. The discussions centered on establishing therapeutic area priorities and identifying potential alignments for future clinical development activities.

Held at the Lütfi Kırdar ICEC on October 15–17, 2025, the Bioexpo 2025 Symposia successfully bridged science and industry across Turkey's life sciences ecosystem. The event delivered critical insights across three core themes: Day 1: Biotech & Clinical Innovation – Explored Turkey's domestic R&D capacity, advancements in clinical trials, biosimilars, and AI in drug discovery. Day 2: Economy & Regulation – Focused on value-based healthcare financing, sustainability, and regulatory standards for APIs. Day 3: Advanced Medicine & Manufacturing – Highlighted rare diseases, genomic medicine, and digital manufacturing processes.

Atlant Clinical had the privilege of attending the symposium titled "Current State Assessment in Clinical Research," hosted by İzmir Tınaztepe University on June 27, 2025. The event brought together academics, researchers, and healthcare professionals to evaluate the sector's evolving landscape. The discussions centered on key strategic areas, including: Market Dynamics & Trends, Ecosystem Growth, and Operational Excellence.

It was a pleasure to attend the fifth scientific meeting of AnkaTheraHub, held in Ankara on Friday, February 28, 2025. The seminar provided an exceptional platform where leading experts, researchers, and industry stakeholders came together to evaluate the latest advancements, address current challenges, and explore innovative methodologies in clinical research.

Organized by the Hacettepe University Vaccine Institute in Ankara, the seminar titled "Access to Innovative Medicines and Sustainability: A Value-Based Approach" introduced a paradigm-shifting framework for delivering medical treatments to society. This innovative approach advocates for evaluating pharmaceutical therapies not merely by their production costs, but by the tangible therapeutic benefits and real-world value they deliver to patients.

Başkent University organized a comprehensive "Clinical Research in Oncology" meeting at the Başkent University Ankara Hospital on February 7, 2025. This meeting was the inaugural event held specifically to mark the establishment of the university's Good Clinical Practices Center of Excellence (BİKUMM). The meeting addressed the importance of clinical trials in cancer treatment, the perspectives of pharmaceutical companies, and current practices in our country.

The 6th National Clinical Research Congress served as a powerful reminder of our collective passion for this field. It was inspiring to witness such a strong spirit of collaboration as site and institution-level stakeholders, country directors, and representatives from the Turkish Medicines and Medical Devices Agency (TİTCK) came together. This year's event offered deep insights into the future of our industry, focusing on critical advancements in digital transformation, data security, and patient-centric approaches.

The 2nd Innovative Medicines Symposium was held by AIFD on November 27th at Ankara Bilkent City Hospital. This year, the symposium featured a multidimensional discussion on "Value-Based Pricing and Reimbursement Systems" with participation from health sector stakeholders, especially public representatives.